Correlation Between Hear Atlast and Predictive Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hear Atlast and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hear Atlast and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hear Atlast Holdings and Predictive Oncology, you can compare the effects of market volatilities on Hear Atlast and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hear Atlast with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hear Atlast and Predictive Oncology.

Diversification Opportunities for Hear Atlast and Predictive Oncology

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Hear and Predictive is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Hear Atlast Holdings and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Hear Atlast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hear Atlast Holdings are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Hear Atlast i.e., Hear Atlast and Predictive Oncology go up and down completely randomly.

Pair Corralation between Hear Atlast and Predictive Oncology

Given the investment horizon of 90 days Hear Atlast Holdings is expected to generate 1.86 times more return on investment than Predictive Oncology. However, Hear Atlast is 1.86 times more volatile than Predictive Oncology. It trades about 0.05 of its potential returns per unit of risk. Predictive Oncology is currently generating about -0.03 per unit of risk. If you would invest  0.20  in Hear Atlast Holdings on August 25, 2024 and sell it today you would lose (0.15) from holding Hear Atlast Holdings or give up 75.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Hear Atlast Holdings  vs.  Predictive Oncology

 Performance 
       Timeline  
Hear Atlast Holdings 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hear Atlast Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Hear Atlast disclosed solid returns over the last few months and may actually be approaching a breakup point.
Predictive Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Hear Atlast and Predictive Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hear Atlast and Predictive Oncology

The main advantage of trading using opposite Hear Atlast and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hear Atlast position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.
The idea behind Hear Atlast Holdings and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope